Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2024/01/01
-
Indian UGC (journal)
-
Refrences90
-
Joban Vaishnav
-
Emily Brown
-
Kavita Sharma
Cite
Vaishnav, Joban, et al. “Advances in the Diagnosis and Treatment of Transthyretin Amyloid Cardiomyopathy”. Progress in Cardiovascular Diseases, vol. 82, 2024, pp. 113-24, https://doi.org/10.1016/j.pcad.2024.01.013.
Vaishnav, J., Brown, E., & Sharma, K. (2024). Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy. Progress in Cardiovascular Diseases, 82, 113-124. https://doi.org/10.1016/j.pcad.2024.01.013
Vaishnav, Joban, Emily Brown, and Kavita Sharma. “Advances in the Diagnosis and Treatment of Transthyretin Amyloid Cardiomyopathy”. Progress in Cardiovascular Diseases 82 (2024): 113-24. https://doi.org/10.1016/j.pcad.2024.01.013.
Vaishnav J, Brown E, Sharma K. Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy. Progress in Cardiovascular Diseases. 2024;82:113-24.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the blood and blood-forming organs
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the circulatory (Cardiovascular) system
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the respiratory system
Medicine
Medicine (General)
You May Also Like
- COVID-19 and Multiorgan Response
- Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries
- Increasing Diversity in Clinical Trials: Overcoming Critical Barriers
- Epidemiology of Diabetes Mellitus and Cardiovascular Disease
- Psychological Stress, Inflammation, and Coronary Heart Disease
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis | Current Opinion in Neurology |
| 2016 | |
| Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid | New England Journal of Medicine |
| 2023 | |
| Patisiran treatment in patients with transthyretin cardiac amyloidosis | New England Journal of Medicine |
| 2023 | |
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy | JAMA |
| 20 | 2023 |
| Phenotypes associated with the Val122Ile, Leu58His, and late-onset Val30Met variants in patients with hereditary transthyretin amyloidosis | Neurology |
| 2023 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system 87
is the most frequently represented among the references in this article. It primarily includes studies from Journal of the American College of Cardiology and Circulation. The chart below illustrates the number of referenced publications per year.